We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Lung Cancer

Expert Opinion / Cases · April 21, 2022

EGFR Exon 20 Insertions: Welcoming the New Treatment Paradigm

Written by
Michael J. Grant MD


Discuss This item Follow

No comments yet, be the first to start the discussion!

  • Tahar GUESMIA

    Apr 22, 2022

    1- Carboplatin and pemetrexed plus pembrolizumab
    2- Amivantamab or Mobocertinib

  • Carlos Delfino

    Apr 22, 2022

    Carboplatin and pemetrexed plus pembrolizumab

  • claudio sini

    Apr 23, 2022


  • Jul 04, 2022

    Pending Moderator approval.

Further Reading